Select the maximum tolerated dose (MTD) when the single-agent trial is completed
select.mtd(target, npts, ntox, cutoff.eli=0.95, extrasafe=FALSE, offset=0.05,
boundMTD=FALSE,p.tox=1.4*target)
the target DLT rate
a vector containing the number of patients treated at each dose level
a vector containing the number of patients who experienced dose-limiting toxicity at each dose level
the cutoff to eliminate overly toxic doses for safety. We recommend
the default value of (cutoff.eli=0.95
) for general use.
set extrasafe=TRUE
to impose a more strict stopping rule for
extra safety
a small positive number (between 0
and 0.5
) to control how strict the
stopping rule is when extrasafe=TRUE
. A larger value leads to
a more strict stopping rule. The default value offset=0.05
generally works well.
set boundMTD=TRUE
to impose the condition: the isotonic estimate of toxicity
probability for the selected MTD must be less than de-escalation boundary.
the lowest toxicity probability that is deemed overly toxic such
that deescalation is required. The default value is
p.tox=1.4*target
.
select.mtd()
returns (1) target toxicity probability ($target
), (2) selected MTD ($MTD
),
(3) isotonic estimate of the DLT probablity at each dose and associated \(95\%\) credible interval ($p_est
),
and (4) the probability of overdosing defined as \(Pr(toxicity>\code{target}|data)\) ($p_overdose
)
select.mtd()
selects the MTD based on isotonic estimates of toxicity
probabilities. select.mtd()
selects as the MTD dose \(j^*\), for which the
isotonic estimate of the DLT rate is closest to the target. If there
are ties, we select from the ties the highest dose level when the estimate
of the DLT rate is smaller than the target, or the lowest dose level
when the estimate of the DLT rate is greater than the target. The
isotonic estimates are obtained by the pooled-adjacent-violators algorithm
(PAVA) (Barlow, 1972).
Liu S. and Yuan, Y. (2015). Bayesian Optimal Interval Designs for Phase I Clinical Trials, Journal of the Royal Statistical Society: Series C, 64, 507-523.
Yan, F., Zhang, L., Zhou, Y., Pan, H., Liu, S. and Yuan, Y. (2020).BOIN: An R Package for Designing Single-Agent and Drug-Combination Dose-Finding Trials Using Bayesian Optimal Interval Designs. Journal of Statistical Software, 94(13),1-32.<doi:10.18637/jss.v094.i13>.
Yuan Y., Hess K.R., Hilsenbeck S.G. and Gilbert M.R. (2016). Bayesian Optimal Interval Design: A Simple and Well-performing Design for Phase I Oncology Trials, Clinical Cancer Research, 22, 4291-4301.
Tutorial: http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/BOIN2.6_tutorial.pdf
Paper: http://odin.mdacc.tmc.edu/~yyuan/Software/BOIN/paper.pdf
# NOT RUN {
### select the MTD for BOIN single agent trial
n <- c(3, 3, 15, 9, 0)
y <- c(0, 0, 4, 4, 0)
selmtd <- select.mtd(target=0.3, npts=n, ntox=y)
summary(selmtd)
plot(selmtd)
# }
Run the code above in your browser using DataLab